Acasti pharma to present at sidoti virtual investor conference on january 18

Laval, quÉbec, jan. 13, 2023 (globe newswire) -- acasti pharma inc. (“acasti” or the “company”) (nasdaq: acst and tsx-v: acst), a late-stage, specialty pharma company advancing three clinical stage drug candidates addressing rare and orphan diseases, today announced jan d'alvise, ceo, will present and host one-on-one meetings with investors at the sidoti january virtual investor conference, taking place on january 18-19, 2023.
ACST Ratings Summary
ACST Quant Ranking